• MK-1775: Reading Wee1 Checkpoint Biology

  2026-09-09

  Explore how MK-1775, a selective Wee1 kinase inhibitor, changes the interpretation of cancer drug-response assays. This guide connects checkpoint biology with the crucial distinction between growth inhibition and true cell killing.

• Trametinib and the Next Layer of MAPK Translation

  2026-09-08

  Trametinib (GSK1120212) offers a precise way to connect MEK-ERK pathway suppression with cell-state outcomes while opening a disciplined research question around APEX2-dependent TERT expression. This thought-leadership framework combines mechanistic biology, assay design, translational interpretation, and practical guidance for oncology researchers.

• Biotin-HPDP for Reversible Thiol Labeling

  2026-09-08

  Biotin-HPDP combines selective cysteine-thiol chemistry with a cleavable disulfide linkage, supporting S-nitrosylation studies, affinity enrichment, and redox-sensitive protein workflows. Its reversible design is especially useful when biochemical capture must be paired with functional studies such as TRPV1 palmitoylation and pain signaling.

• FPS-ZM1: RAGE Inhibitor Assay Guide

  2026-09-07

  A scenario-based guide to using FPS-ZM1 (SKU C3723) to investigate RAGE-dependent effects in viability, cytotoxicity, metabolic-stress, and neuroinflammation experiments. It connects solvent control, assay design, interpretation, and vendor selection with current RAGE/POMC and amyloid beta evidence.

• APS–miR-183-5p Activates Keap1-Nrf2 in Fish Cells

  2026-09-07

  The reference study identifies miR-183-5p as a mechanistic link between Astragalus polysaccharides and Keap1-Nrf2 antioxidant signaling in large yellow croaker head kidney cells. Its findings connect improved redox control with reduced mitochondrial injury, apoptosis, and pyroptosis, while also clarifying how cell-based oxidative-stress models can inform aquaculture and programmed cell death research.

• Nocodazole Workflows for Microtubule Dynamics

  2026-09-05

  Nocodazole converts microtubule disruption into a controllable experimental variable for cell-cycle, trafficking, and infection-entry studies. This guide translates evidence from Drosophila S2 cell infection research into practical dosing, washout, imaging, and troubleshooting strategies.

• Neuromedin S (rat): Practical GPCR Workflow

  2026-09-04

  Neuromedin S (rat) provides a chemically defined endogenous peptide agonist for controlled neuromedin U receptor signaling and GPCR/G protein signaling assays. It is intended for research workflows, with defined handling and storage requirements, and should not be used for diagnostic, medical, or therapeutic purposes.

• Polygodial: TRPA1 Channel Activator Research Guide

  2026-09-04

  Polygodial is a DMSO-soluble TRPA1 channel activator for controlled ion-channel, sensory-neuron, and epithelial signaling studies. The reference study links TRPA1 activation with calcium influx, NFAT activity, and TSLP production, but it does not establish polygodial-specific activity in nasal epithelial cells.

• Allosteric PDK4 Inhibitors: Study Insights

  2026-09-03

  Lee and colleagues developed an anthraquinone-derived series of allosteric pyruvate dehydrogenase kinase 4 inhibitors and identified compound 8c as a potent biochemical inhibitor with favorable early drug-discovery properties. The study connected PDK4 inhibition with improved glucose tolerance, reduced allergic responses, and anticancer phenotypes, while also showing why enzyme potency, pharmacokinetics, and disease-model outcomes must be interpreted separately.

• Phenothiazines, ROS, and Autophagy in Antibacterial Macropha

  2026-09-03

  Qiu et al. show that phenothiazines can strengthen macrophage control of intracellular bacteria by increasing lysosomal activity, reactive oxygen species, and autophagy. Inhibitor and scavenger experiments support a host-directed mechanism, while the perphenazine infection model provides in vivo evidence that this strategy can reduce Salmonella-associated tissue damage and inflammation.

• Cy3 Goat Anti-Rabbit IgG (H+L) Antibody Workflow

  2026-09-02

  Build sensitive, flexible rabbit-primary detection into immunofluorescence, ICC, IHC, and flow cytometry workflows with a Cy3-conjugated secondary antibody. This practical guide translates a hyperoxia–ATII cell study into assay design, multiplex imaging, quantitative analysis, and troubleshooting decisions.

• Microneedle Gene Delivery for Glaucoma Mitochondria

  2026-09-02

  The 2026 Biomaterials study develops an annular sector-shaped microneedle patch for local delivery of an Nmnat1 gene-loaded lipid nanoparticle formulation together with nicotinamide to the trabecular meshwork. In cellular and dexamethasone-induced mouse glaucoma models, this combination improved mitochondrial dysfunction, reduced intraocular pressure, and alleviated trabecular meshwork fibrosis, while also illustrating the opportunities and limitations of localized ocular gene delivery.

• HyperFluor 488 Goat Anti-Rabbit IgG Guide

  2026-09-01

  HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody is a fluorescent secondary reagent for detecting rabbit IgG primary antibodies in immunofluorescence, flow cytometry, and fluorescence microscopy. It should not be used as a universal secondary for non-rabbit primaries, non-fluorescent detection systems, or live-cell workflows without compatibility validation.

• Boc-D-FMK Workflows for Apoptosis Research

  2026-09-01

  Boc-D-FMK provides a practical, cell-permeable way to test whether activated caspases drive apoptosis and inflammation in cell and animal models. This guide connects assay design, formulation, pathway readouts, and fibrosis-oriented applications while clarifying what the inhibitor can—and cannot—demonstrate.

• SmD2 Acetylation Rewires PARP Sensitivity in HCC

  2026-08-31

  A 2024 Nature Communications study identifies acetylation of the core spliceosome protein SmD2 as a regulatory link between alternative splicing, BRCA1/FANC expression, DNA repair, and PARP inhibitor response in hepatocellular carcinoma. The findings support testing SmD2–HDAC2–p300 biology as a biomarker-guided strategy for sensitizing BRCA-proficient HCC models to PARP inhibition.

8600 records 8/574 page Previous Next First page 上5页 678910 下5页 Last page